Trial
NCT01808534
Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
Alaunos Therapeutics
Condition
Adult Central Nervous System Germ Cell Tumor
Intervention
palifosfamide
Why stopped
Due to Low Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-07-02